chr16-88427940-G-A
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBS1_Supporting
The NM_001367624.2(ZNF469):c.470G>A(p.Gly157Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000342 in 1,549,810 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. G157G) has been classified as Likely benign.
Frequency
Consequence
NM_001367624.2 missense
Scores
Clinical Significance
Conservation
Publications
- brittle cornea syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, Genomics England PanelApp
- brittle cornea syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- aortic disorderInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001367624.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ZNF469 | NM_001367624.2 | MANE Select | c.470G>A | p.Gly157Glu | missense | Exon 3 of 3 | NP_001354553.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ZNF469 | ENST00000565624.3 | TSL:6 MANE Select | c.470G>A | p.Gly157Glu | missense | Exon 3 of 3 | ENSP00000456500.2 | ||
| ZNF469 | ENST00000437464.1 | TSL:5 | c.470G>A | p.Gly157Glu | missense | Exon 1 of 2 | ENSP00000402343.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152062Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.0000410 AC: 6AN: 146208 AF XY: 0.0000634 show subpopulations
GnomAD4 exome AF: 0.0000358 AC: 50AN: 1397748Hom.: 1 Cov.: 33 AF XY: 0.0000392 AC XY: 27AN XY: 689398 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152062Hom.: 0 Cov.: 34 AF XY: 0.0000269 AC XY: 2AN XY: 74260 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge
This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 157 of the ZNF469 protein (p.Gly157Glu). This variant is present in population databases (rs781096189, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with ZNF469-related conditions. ClinVar contains an entry for this variant (Variation ID: 320853). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Brittle cornea syndrome 1 Uncertain:2
This variant was classified as: Uncertain significance. The following ACMG criteria were applied in classifying this variant: PM2.
Myopia;C0152459:Striae distensae;C1697453:Spontaneous hematomas;C1844592:Soft skin;C1844820:Joint hypermobility;C1851789:Poor wound healing;C1857790:Thoracic scoliosis;C4317146:Gastroesophageal reflux Uncertain:1
Cardiovascular phenotype Uncertain:1
The c.470G>A (p.G157E) alteration is located in exon 1 (coding exon 1) of the ZNF469 gene. This alteration results from a G to A substitution at nucleotide position 470, causing the glycine (G) at amino acid position 157 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at